CAV1 and type 2 diabetes mellitus: Based on our results, we propose that ALS-T2DM-IgGs serve as autoantibodies that immunocapture CaVα2δ1 subunits in the plasma membrane, thereby enhancing CaV1 channel-mediated Ca2+ influx and [Ca2+]i in islet cells.